Susan G. Komen history: founding, impact, and famous fundraisers

Susan G. Komen tells its own history in personal terms, not institutional ones. Its materials describe the group's start as "a sisterly promise." In its own words, that promise "ignited a spark that would fuel a global crusade against breast cancer."

That is an intimate story for a large national nonprofit. Komen leads with it anyway. The group does not say it started with a committee or a grant. It says it started with a bond between two people, and a promise made within it.

Komen calls itself "the ONLY organization that addresses breast cancer on multiple fronts." Those fronts are research, community health, global outreach, and public policy. In other words, Komen does not pick just one lane, such as only funding lab research or only running local support groups. It says it works on several fronts at once.

Whether or not Komen is truly the only group doing this, that claim describes what Komen's own materials say it tries to do.

Komen's own numbers describe a large, long-running research investment. It reports investing nearly $3.6 billion in research and programs across more than 60 countries.

It also credits its funded research with helping make 29 new breast cancer drugs possible over roughly the past 30 years. That is a claim about contributing to a bigger research pipeline. It is not a claim of sole credit for any one drug, since drug development usually involves many funders and research groups working side by side.

Komen also points to a bigger trend. It reports that breast cancer deaths have fallen 44% since 1989. Many things have driven that drop over decades: earlier detection, more screening, and treatment advances across the whole field. Komen presents its own funding as one part of that larger story, not the only cause of it.

For many people, Komen means its events, not its research budget. Race for the Cure is Komen's best-known event. It is a community race held in cities across the country for decades, and it is closely tied to Komen's pink-ribbon image.

The 3-Day Walk is another major fundraising walk. Komen's site also lists galas, concerts, and do-it-yourself fundraising as other ways people raise money for its work.

Komen can point to decades of breast cancer research. It can connect people to community health programs and to policy work focused on breast cancer. It offers a large, visible network for anyone who wants to fundraise, join an event, or find community after a diagnosis. Because it works on several fronts at once, it is often a useful starting point for more than one kind of help.

Komen does not diagnose or treat breast cancer, and it does not manage anyone's care. Those choices stay with a patient and their own oncology team.

Its research claims describe a contribution to a whole field, not proof that any one treatment traces back to Komen alone. Its reported drop in deaths reflects trends across all of cancer care, not results from Komen by itself.

Any financial help Komen offers depends on limited funds and rules that change over time. A general description of a program is not a promise that your case will be approved. Always confirm current details directly with Komen.

Komen's own story is simple: a personal promise, grown over decades into research funding, community programs, global work, and policy advocacy. That explains how a group named after one woman now works across dozens of countries.

For a patient or caregiver, the useful takeaway is this. Komen says it works on more than one front at once. That is a good reason to check Komen's current site for more than one kind of help, not just research funding or just events.